Close
Xylem
Novotech

Upsher-Smith launches new prenatal vitamin

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

US Clinical Trials Plan Aims to Restore Research Leadership

The US Department of Health and Human Services (HHS)...

Lilly and BioArctic Partner on BrainTransporter Technology

Eli Lilly and Company has entered into a research...

AbbVie Acquires Apogee in $10.9 Billion Healthcare Deal

In a significant expansion of its research and development...
- Advertisement -

Upsher-Smith Laboratories has launched B-Nexa, a prescription prenatal vitamin for pregnant women who suffer from nausea and vomiting of pregnancy (NVP).

B-Nexa is designed with B vitamins and ginger to help calm NVP, also known as morning sickness, the most common symptom of pregnancy, the company said.ย Taken once or twice daily, B-Nexa contains vitamin B6 and ginger to help calm nausea and vomiting during pregnancy. Each antihistamine-free tablet also contains 1.2mg folic acid.

Upsher-Smith medical affairs senior director Wesley Todd said that B-Nexa is a new option in the prenatal nutrition market that has been designed to help calm nausea and vomiting of pregnancy.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

US Clinical Trials Plan Aims to Restore Research Leadership

The US Department of Health and Human Services (HHS)...

Lilly and BioArctic Partner on BrainTransporter Technology

Eli Lilly and Company has entered into a research...

AbbVie Acquires Apogee in $10.9 Billion Healthcare Deal

In a significant expansion of its research and development...

The Growing Challenge of Patient Non-Compliance in Modern Healthcare

Advances in medical research, pharmaceutical innovation, and healthcare technology...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป